![](/img/cover-not-exists.png)
Phase II pilot trial of gemtuzumab ozogamicin (GO) as first line therapy in acute myeloid leukemia patients age 65 or older
Chadi Nabhan, Lynn M. Rundhaugen, Mary B. Riley, Alfred Rademaker, Larry Boehlke, Mashal Jatoi, Martin S. TallmanVolume:
29
Year:
2005
Language:
english
Pages:
5
DOI:
10.1016/j.leukres.2004.04.011
File:
PDF, 66 KB
english, 2005